Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat severe and life-threatening diseases. Founded by David Scadden, Dhvanit Shah, and Sean Morrison in 2021Garuda Therapeutics is backed by Resilience, OrbiMed, Cormorant Asset Management, Northpond Ventures, and Aisling Capital and is headquartered in Natick.